![]() |
![]() |
|
|
|
College of PharmacyPharmaceutical Sciences - Health Outcomes and Policy Research |
|||||||
|
Publications and PresentationsPublicationsWang J, Mullins CD, Zuckerman IH, Walker GD, Suda KJ, Yang Y, White-Means SI. Medical Expenditure Panel Survey: a valuable database for studying racial and ethnic disparities in prescription drug use. Research in Social & Administrative Pharmacy. In print. Wang J, Zuckerman IH, Miller NA, Shaya FT, Noel JM, Mullins CD. Accessing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Health Services Research. In print. Wang J, Miller N, Hufstader M, Bian Y. The Health status of Asian Americans and Pacific Islanders and their access to health services. Journal of Health and Social Policy. In print. Wang J, White-Means SI, Hufstader MA, Walker GD. The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors. Current Medical Research & Opinion. 2007;23(4):853-863. Wang J, Saalfrank MA, Hong SH, Liu C, Gourley DR. Patterns of reporting health-related quality of life across racial and ethnic groups. Expert Review of Pharmacoeconomics & Outcomes Research. 2007;7(2):177-186. Wang J, Noel JM, Zuckerman IH, Miller NA, Shaya FT, Mullins CD. Racial and ethnic disparities in access to new, essential prescription drugs. Medical Care Research and Review 2006;63(6):742-763. Mullins CD, Shaya FT, Meng F, Wang J, Bron MS. Comparison of first refill rates among branded SSRI users. Clinical Therapeutics 2006;28(2):297-305. Mullins CD, Shaya FT, Meng F, Wang J, Harrison D. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy 2005;25(5):660-7. Mullins CD, Snyder SE, Wang J, Cooke JL, Baquet C. Economic disparities in treatment costs among ambulatory Medicaid cancer patients. Journal of the National Medical Association 2004;96(12):1565-74. Zuckerman IH, Weiss SR, McNally D, Layne B, Mullins CD, Wang J. Impact of an educational intervention for secondary prevention of myocardial infarction on Medicaid drug use and cost. The American Journal of Managed Care 2004;10(7):493-500. Mullins CD, Cooke JL, Wang J, Shaya FT, Hsu VD, Brooks S. Disparities in prevalence rates for lung, colorectal, breast and prostate cancers in Medicaid. Journal of the National Medical Association 2004;96(6):809-16. Mullins CD, Wang J, Cooke JL, Blatt L, Baquet CR. Longitudinal versus cross-sectional methodology for estimating the economic burden of breast cancer: a pilot study. Pharmacoeconomics 2004;22(5):285-91. Mullins CD, Wang J, Stoller J. Major components of the direct medical costs of a1-antitrypsin deficiency. Chest 2003;124(3):826-31. Mullins CD, Blatt L, Wang J. Societal implications of the pharmacoeconomics of a1-antitrypsin deficiency. Expert Review of Pharmacoeconomics & Outcomes Research 2002; 2(3):243-9. Mullins CD, Wang J. Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making. Pharmacoeconomics 2002;20(1):9-21. Mullins CD, Wang J, Palumbo FB, Stuart B. The impact of pipeline drugs on drug spending growth. Health Affairs 2001;20(5):210-5. PresentationsWang J, Dong Z. Direct medical costs across racial and ethnic groups among children with cancer. Podium Presentation. American Public Health Association Annual Meeting. Washington, DC, November, 2007. Wang J, Hufstader M. Are there differential returns of health expenditures between different income levels? Poster. Southern Pharmacy Administration Conference, 2007. Little Rock, AR, June, 2007. Wang J, Mullins CD, White-Means SI, Chang CF. Changes in health expenditures and in health status from 1996 to 2004 across racial and ethnic groups. Implications for health care financing. Invited Presentation. Division of Internal Medicine, Department of Medicine, University of Tennessee, May, 2007. Wang J, Dong Z. Direct medical costs across racial and ethnic groups among children with cancer. Poster. American College of Clinical Pharmacy 2007 Spring Practice and Research Forum. Memphis, TN, April, 2007. Wang J, White-Means SI, Walker GD. Racial and ethnic disparities in the use of selective serotonin reuptake inhibitors and their effects on per capita health expenditures. Podium presentation, American Public Health Association Annual Meeting. Boston, MA, November, 2006. Wang J, Mullins CD, Zuckerman IH, White-Means SI, Hufstader MA, Walker GD. Comparison of changes in health care expenditure and self-perceived health status from 1996 to 2001 across racial and ethnic groups in the United States. Poster, AcademyHealth Annual Research Meeting. Seattle, WA, June, 2006. Wang J, Mullins CD, Zuckerman I, White-Means SI, Arreola R, Hufstader MA, Hutchison L, Walker GD. Differential racial and ethnic disparities in health expenditure and self-perceived health status in the United Status. Podium presentation, International Society for Pharmacoeconomics and Outcomes Research 11th Annual International Meeting. Philadelphia, PA, May, 2006. Zuckerman IH, Du D, Royak-Schaler R, Wang J. Mammography screening use among Medicare beneficiaries age 65 or older. Podium presentation, International Society for Pharmacoeconomics and Outcomes Research 11th Annual International Meeting. Philadelphia, PA, May, 2006. Wang J, Mullins CD. Racial and Ethnic Disparities in Access to New Essential Prescription Drugs. Third Annual Health Services Research Day. Podium Presentation, University of Tennessee. Memphis, TN. March 2006. Wang J, Mullins CD. Accessing new prescription drugs: racial and ethnic disparities. Third Annual Health Services Research Day. Poster, University of Tennessee. Memphis, TN. March 2006. Wang J, Mullins CD. Racial/ethnic disparities in access to essential prescription drugs during early years of drug products’ life cycles. Podium presentation, American Public Health Association. Philadelphia, PA, December, 2005. Wang J. Racial and ethnic disparities in the use of prescription drugs. Invited seminar. Department of Economics, University of Memphis. Memphis, TN, October, 2005. Johnson A, Wang J, White-Means S. Drug marketing attitudes and healthcare utilization among pharmacy students, faculty, and staff. Poster, National Pharmaceutical Association Annual Meeting. Orlando, FL, July, 2005. Wang J, Mullins CD. Racial/ethnic disparities in access to new prescription drugs. Podium presentation, AcademyHealth Annual Research Meeting. Boston, MA, June, 2005. Mullins CD, Snyder SE, Wang J, Cooke JL, Baquet C. Disparities in Medicaid cancer expenditures. Poster, International Society for Pharmacoeconomics and Outcomes Research 7th Annual European Congress. Hamburg, Germany, October, 2004. Zuckerman IH, Weiss SR, McNally D, Layne B, Mullins CD, Wang J. Impact of an outpatient physician education program on beta-blocker usage for secondary prevention of myocardial infarction. Poster, the 20th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Bordeaux, France, August, 2004. Wang J, Mullins CD, Shaya F, Meng F, Harrison D. Switching and discontinuation of sertraline, paroxetine, and citalopram therapy. Poster, International Society for Pharmacoeconomics and Outcomes Research 9th Annual International Meeting, Arlington, VA, May, 2004. Shaya F, Mullins CD, Meng F, Wang J, Harrison D. Second SSRIs switching and discontinuation after fluoxetine initial therapy. Poster, International Society for Pharmacoeconomics and Outcomes Research 9th Annual International Meeting, Arlington, VA, May, 2004. Mullins CD, Shaya F, Meng F, Wang J, Bron MS. Comparison of first refill rates among branded SSRI users. Poster, International Society for Pharmacoeconomics and Outcomes Research 9th Annual International Meeting, Arlington, VA, May, 2004. Wang J, Mullins CD, Shaya F, Meng F, Harrison D. Switching and discontinuation of sertraline, paroxetine, and citalopram therapy. Poster, American Psychiatric Association 157th Annual Meeting, New York, NY, May, 2004. Mullins CD, Shaya F, Meng F, Wang J, Bron MS. Comparison of first refill rates among branded SSRI users. Poster, American Psychiatric Association 157th Annual Meeting, New York, NY, May, 2004. Wang J, Mullins CD, Stoller JK. Major components of the direct medical costs of the alpha-1 antitrypsin deficiency. Poster, Drug Information Association 39th Annual Meeting, San Antonio, TX, June, 2003. Wang J, Mullins CD, Stoller JK. Major components of the direct medical costs of the alpha-1 antitrypsin deficiency. Poster, School of Pharmacy Research Day, University of Maryland, Baltimore, MD, May, 2003. Wang J, Mullins CD, Stoller, JK. Major components of the direct medical costs of the alpha-1 antitrypsin deficiency. Poster, 25th Annual Graduate Research Conference, University of Maryland, Baltimore and University of Maryland, Baltimore County, Baltimore, MD, April, 2003. Mullins CD, Wang J, Palumbo FB, Stuart B. The impact of pipeline drugs on drug spending growth. Podium presentation, International Society for Pharmacoeconomics and Outcomes Research 4th Annual European Congress, Cannes, France, November, 2001. Wang J, Miller NA. The health access status of Asian Americans. Podium presentation, American Public Health Association 128th Annual Meeting, Boston, MA, November, 2000. Additional Publications in ChineseWang J, Xu L, Zhao M, Wang X, Liu Y, Zhao X. The status and determinants of health education of women in rural Shandong. Journal of Chinese Maternal and Child Health 1999;14(10): 621-2. Wang J. Let me speak out for you. China Leprosy Journal 1998;14(2):103-4. Wang J, Meng Q, Ma Y, et al. The evaluation of the measures and policies for Leprosy control. Journal of Chinese Health Services Management 1997;13(9):465-7. Wang J, Meng Q, Ma Y, et al. The method evaluating economic efficiency of health institutions. Journal of Chinese Health Services Management 1997;13(10):542-5. Wang J, Meng Q, Xu L, et al. The economic efficiency of Leprosy Control Stations in Shandong. Journal of Chinese Health Services Management 1997;13(10):546-9. Wang J, Meng Q, Xu L, et al. The determinants of index of inefficiency of Leprosy Control Stations in Shandong. Journal of Chinese Health Services Management 1997;13(10):550-3. Wang J, Ma Y, Xu L, et al. The history and evolution of Leprosy Villages in Shandong. Journal of Chinese Health Services Management 1997;13(10):554-6. Wang J, Meng Q. The regulations and laws of health insurance of the United States. Foreign Medicine, Health Economics Branch 1997;14(1):1-4. Wang J. The prescription for public hospitals of the United States. Foreign Medicine, Health Economics Branch 1997;14(4):165-8. Jia L, Wang J. Community medicine. In: Jiao C, Cao J, and Liu Y. (Editors). Overview of New Medical Disciplines. Beijing: Chinese Medical Technology Publishing House; 2001:546-60. Meng Q, Wang J. The regulations and laws that affect the demand and supply of health services in the United States. Foreign Medicine, Health Economics Branch 1997;14(2):69-74. Meng Q, Xu L, Wang J, et al. The financing of Leprosy Control Stations I: funds from the government. Journal of Chinese Health Services Management 1997;13(9):452-4. Meng Q, Xu L, Wang J, et al. The financing of Leprosy Control Stations II: funds from the Leprosy Control Stations. Journal of Chinese Health Services Management 1997;13(9):455-7. Xu L, Meng Q, Wang J, et al. Health services supply in Leprosy Control Stations at the county level in Shandong, China. Journal of Chinese Health Services Management 1997;13(9):468-70, 476. Zhao M, Xu L, Wang X, Wang J, Liu Y, Sun X. The determinants for the coverage rate of Maternal and Child Health Insurance System. Chinese Maternal and Child Health 1999;14 (9):346-8. Zhao M, Wang X, Xu L, Wang J, Sun X, Liu Y. Health service utilization and its determinants among rural prenatal and postnatal women in Jining Prefecture, Shandong Province. Chinese Primary Health Care 1999;13(9):26-7. Xu L, Zhao M, Liu X, Wang J, et al. The background, research problem and research framework for the study on the Maternal and Child Health Insurance System. Journal of Chinese Rural Health Services Management 1999:19(10):36-7. Zhao M, Wang X, Xu L, Wang J, et al. The impact of Maternal and Child Health Insurance Scheme on the health status of prenatal and postnatal women. Journal of Chinese Rural Health Services Management 1999:19(10):38-9. Zhao M, Xu L, Wang X, Wang J, Liu K, Dong F. Maternal and Child Health Insurance Scheme on the direct medical cost of rural prenatal and postnatal woman. Journal of Chinese Rural Health Services Management 1999:19(10):39-40. Xu L, Zhao M, Wang X, Wang J, et al. The summary and policy recommendations from the study on the Maternal and Child Health Insurance Scheme. Journal of Chinese Rural Health Services Management 1999:19(10):41-2. Zhao, M, Xu L, Wang X, Wang J, Liu Y, Sun X. The determinants of birth sites in rural Shandong. Journal of Chinese Rural Health Services Management 1999:19(5):43-5. Zhao M, Xu L, Wang X, Wang J. Preference of rural residents over Maternal and Child Health Insurance Scheme. Journal of Chinese Rural Health Services Management 1999:19(10):346-8. Xu L, Meng Q, Liu X, Wang J, et al. Leprosy prevalence in Shandong. Journal of Chinese Health Services Management 1997;13(9):458-60. |
||||||
| Copyright ©2003 The University of Tennessee Health Science Center · Memphis, Tennessee 38163 · Telephone 901-448-5500 | |